CDMO News
Asahi Kasei Bioprocess and Axolabs to Accelerate Oligonucleotide Therapeutics Production
Asahi Kasei Bioprocess (AKB), a part of the Asahi Kasei Group, and Axolabs have announced their partnership to construct a new oligonucleotide cGMP manufacturing facility in Berlin. The facility, spanning an impressive 59,000 square feet, is a significant step towards